HM
DMAQR

Howard Marks’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Howard Marks’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-425,000
Closed -$136K – 407
2021
Q4 		$136K Buy
+425,000
New +$134K ﹤0.01% 343

Other funds holding DMAQR

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

Howard Marks's DMAQR Position: Q1 2022 in Review

Howard Marks sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2022, closing a stake of 425,000 shares — an estimated $136K sold.

Howard Marks first reported a position in DMAQR in Q4 2021 and held it in 1 quarter. The position peaked at $136K in Q4 2021. 28 funds tracked by Wall St. Rank hold DMAQR as of Q1 2022.

  • Howard Marks reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2022 after selling out during the quarter.
  • Howard Marks sold 425,000 Deep Medicine Acquisition Corp. Rights shares in Q1 2022, an estimated $136K.
  • Howard Marks first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 1 quarter.
  • Howard Marks's Deep Medicine Acquisition Corp. Rights position peaked at $136K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2022.

Based on Oaktree Capital Management's 13F filing for Q1 2022, filed 16 May 2022.